The Working Paper sheds light on the extent to which “value” is considered in pricing and/or coverage decisions in 14 OECD member countries. It describes methods used by countries to assess the therapeutic benefits of new products, as well as approaches for economic evaluation, where relevant, and aims to illustrate how value is assessed and what is its impact on pricing and/or reimbursement decisions.
Dementia is a devastating condition for the people affected, their family and friends, and for health systems. Through its global reach and ability to bring together government and non-government perspectives, OECD is in a unique position to face up to the challenge.
L’approche politique actuelle pour lutter contre la démence n’est pas viable socialement et économiquement, selon un nouveau rapport de l’OCDE. Les pays doivent agir immédiatement pour améliorer la vie des personnes atteintes de démence et celle de leurs soignants, donner la priorité à la recherche publique sur la démence, et encourager davantage l’investissement privé dans l’innovation pour la recherche sur la démence.
The large and growing human and financial cost of dementia provides an imperative for policy action. It is already the second largest cause of disability for the over-70s and it costs $645bn per year globally, and ageing populations mean that these costs will grow.
There is no cure or effective treatment for dementia, and too often people do not get appropriate health and care services, leading to a poor quality of life. Our failure to tackle these issues provides a compelling illustration of some of today’s most pressing policy challenges. We need to rethink our research an innovation model, since progress on dementia has stalled and investment is just a fraction of what it is for other diseases of similar importance and profile. But even then a cure will be decades away, so we need better policies to improve the lives of people living with dementia now. Communities need to adjust to become more accommodating of people with dementia and families who provide informal care must be better supported. Formal care services and care institutions need to promote dignity and independence, while coordination of health and care services must be improved. But there is hope: if we can harness big data we may be able to address the gaps in our knowledge around treatment and care.
Dementia is increasing in prevalence, and to date has no cure or treatment. One element in improving this situation is using and sharing data more widely to increase the power of research. Further, moving beyond established medical data into big data offers the potential to tap into routinely collected data from both within and outside the health system.
This Forum does not mark the end of a process. It was a key step aimed at sharing the main conclusions of our work on Mental Health and Work and to discuss where we stand, with the goal of connecting health policy makers and employment policy makers in order to discuss an issue that they can only solve together.
Introductory remarks at the high-level OECD Policy Forum on Mental Health and Work: Bridging Employment and Health Policies, The Hague, Netherlands, 4 March 2015
Il ressort d’un nouveau rapport de l’OCDE que les services de santé et de l’emploi devraient intervenir plus tôt, mettre à contribution les principaux acteurs et faire en sorte de travailler ensemble afin d’aider les personnes atteintes de troubles mentaux à trouver du travail et à le garder.
Mr. Angel Gurría was in The Hague to attend the High-Level Policy Forum on Mental Health and Work Policy Challenges in OECD Countries, where he presented key findings of the OECD Fit Mind Fit Job report and was awarded the Grand Cross of the Order of Orange Nassau.